Risk of Strongyloides Hyperinfection Syndrome when prescribing Dexamethasone in Severe COVID-19. De Wilton A A, Nabarro LE, Godbole GS, Chiodini PL, et al. Travel Med Infect Dis 2021 Jan 31:101981. doi: 10.1016/j.tmaid.2021.101981.

Read + Share

Amedeo Smart

Independent Medical Education

De Wilton A A, Nabarro LE, Godbole GS, Chiodini PL, et al. Risk of Strongyloides Hyperinfection Syndrome when prescribing Dexamethasone in Severe COVID-19. Travel Med Infect Dis 2021 Jan 31:101981. doi: 10.1016/j.tmaid.2021.101981.
PMID: 33535106